The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Subgroup analyses from CheckMate 040.
 
Aiwu Ruth He
Honoraria - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Genentech; Genentech; Genentech; Genentech; Merck; Merck; Merck; Merck
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Merck; Merck; Merck; Merck
Research Funding - Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Regeneron; Regeneron; Regeneron; Regeneron
 
Thomas Yau
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
 
Chiun Hsu
Honoraria - Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; TTY Biopharm; TTY Biopharm; TTY Biopharm; TTY Biopharm
Research Funding - Bristol-Myers Squibb-Ono Pharmaceutical; Bristol-Myers Squibb-Ono Pharmaceutical; Bristol-Myers Squibb-Ono Pharmaceutical; Bristol-Myers Squibb-Ono Pharmaceutical
 
Yoon-Koo Kang
No Relationships to Disclose
 
Tae-You Kim
No Relationships to Disclose
 
Armando Santoro
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; MSD; MSD; MSD; MSD; Pfizer; Pfizer; Pfizer; Pfizer; SERVIER; SERVIER; SERVIER; SERVIER
Speakers' Bureau - Abbvie; Abbvie; Abbvie; Abbvie; Amgen; Amgen; Amgen; Amgen; ArQule; ArQule; ArQule; ArQule; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche; Sandoz; Sandoz; Sandoz; Sandoz; Servier; Servier; Servier; Servier; Takeda; Takeda; Takeda; Takeda
 
Bruno Sangro
Consulting or Advisory Role - Adaptimmune; Adaptimmune; Adaptimmune; Adaptimmune; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; BTG; BTG; BTG; BTG; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Onxeo; Onxeo; Onxeo; Onxeo; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Onxeo (Inst); Onxeo (Inst); Onxeo (Inst); Onxeo (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Other Relationship - Medscape; Medscape; Medscape; Medscape; Target Pharmasolutions; Target Pharmasolutions; Target Pharmasolutions; Target Pharmasolutions
 
Ignacio Melero
Honoraria - Alligator Bioscience; Alligator Bioscience; Alligator Bioscience; Alligator Bioscience; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Tusk Therapeutics; Tusk Therapeutics; Tusk Therapeutics; Tusk Therapeutics
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Biocotech; Biocotech; Biocotech; Biocotech; Biocotech; Biocotech; Biocotech; Biocotech; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; EMD Serono; EMD Serono; EMD Serono; EMD Serono; F-star; F-star; F-star; F-star; Genmab; Genmab; Genmab; Genmab; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Numab; Numab; Numab; Numab; Roche; Roche; Roche; Roche; Tusk Therapeutics; Tusk Therapeutics; Tusk Therapeutics; Tusk Therapeutics; Tusk Therapeutics; Tusk Therapeutics; Tusk Therapeutics; Tusk Therapeutics
Research Funding - Alligator Bioscience; Alligator Bioscience; Alligator Bioscience; Alligator Bioscience; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Pfizer; Pfizer; Pfizer; Pfizer; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Incyte; Incyte; Incyte; Incyte; MSD; MSD; MSD; MSD; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
 
Masatoshi Kudo
Honoraria - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; MSD; MSD; MSD; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; MSD; MSD; MSD; MSD; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)
 
Ming-Mo Hou
No Relationships to Disclose
 
Ana Matilla
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; BTG; BTG; BTG; BTG
Research Funding - Bayer; Bayer; Bayer; Bayer
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer
 
Francesco Tovoli
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer
 
Jennifer J. Knox
Honoraria - Novartis; Novartis; Novartis; Novartis
Consulting or Advisory Role - Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck; Merck; Merck; Merck
 
Bassel F. El-Rayes
Honoraria - Bayer; Bayer; Bayer; Bayer; Lexicon; Lexicon; Lexicon; Lexicon; RTI Health Solutions; RTI Health Solutions; RTI Health Solutions; RTI Health Solutions
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; BTG; BTG; BTG; BTG; Loxo; Loxo; Loxo; Loxo; Merrimack; Merrimack; Merrimack; Merrimack; RTI Health Solutions; RTI Health Solutions; RTI Health Solutions; RTI Health Solutions
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lexicon; Lexicon; Lexicon; Lexicon
Research Funding - AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AVEO (Inst); AVEO (Inst); AVEO (Inst); AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Cleave Biosciences (Inst); Cleave Biosciences (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); Hoosier Cancer Research Network (Inst); Hoosier Cancer Research Network (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); ICON Clinical Research (Inst); ICON Clinical Research (Inst); ICON Clinical Research (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); PPD (Inst); PPD (Inst); PPD (Inst); PPD (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Xencor (Inst); Xencor (Inst); Xencor (Inst); Xencor (Inst)
Other Relationship - ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; Exelixis; Exelixis; Exelixis; Exelixis
 
Mirelis Acosta-Rivera
No Relationships to Disclose
 
Jaclyn Neely
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
 
Yun Shen
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Sanofi (I); Sanofi (I); Sanofi (I); Sanofi (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Bristol-Myers Squibb (I); Sanofi (I); Sanofi (I); Sanofi (I); Sanofi (I)
 
Marina Tschaika
Employment - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
 
Anthony B. El-Khoueiry
Honoraria - Agenus; Agenus; Agenus; Agenus; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; Eisai; Eisai; Eisai; Eisai; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Consulting or Advisory Role - Agenus; Agenus; Agenus; Agenus; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; CytomX Therapeutics; Eisai; Eisai; Eisai; Eisai; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Exelixis; Exelixis; Exelixis; Exelixis; Merck; Merck; Merck; Merck; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Pieris Pharmaceuticals; Roche; Roche; Roche; Roche
Research Funding - Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck; Merck; Merck; Merck